MAGEN BRENNAN: Open Payments
NPI 1497408173 · MARIETTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,902 in 93 payments from 20 companies in 2025. Trend: 2023 $117 · 2024 $1,510 · 2025 $1,902
Food & beverage: $1,902
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $415 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 13 | $218 |
| GENZYME CORPORATION | 7 | $196 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $187 |
| Janssen Biotech, Inc. | 9 | $179 |
| Lilly USA, LLC | 6 | $119 |
| Ardelyx, Inc. | 5 | $103 |
| Madrigal Pharmaceuticals | 3 | $87 |
| QOL Medical, LLC | 2 | $67 |
| Novo Nordisk Inc | 2 | $52 |
Products named: DUPIXENT, XIFAXAN, TREMFYA, SKYRIZI, ENTYVIO, OMVOH, RINVOQ, IBSRELA.
Industry payments across GA — which companies pay providers there.
